Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Metabolic biomarkers for predicting cardiovascular disease.

Montgomery JE, Brown JR.

Vasc Health Risk Manag. 2013;9:37-45. doi: 10.2147/VHRM.S30378. Epub 2013 Jan 29. Review.

PMID:
23386789
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[New biomarkers for cardiovascular risk evaluation].

Chironi G.

Rev Prat. 2012 Jun;62(6):783-5. Review. French.

PMID:
22838270
[PubMed - indexed for MEDLINE]
3.

Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin.

May A, Wang TJ.

Expert Rev Mol Diagn. 2007 Nov;7(6):793-804. Review.

PMID:
18020909
[PubMed - indexed for MEDLINE]
4.

Biomarkers as a guide of medical treatment in cardiovascular diseases.

Vavuranakis M, Kariori MG, Kalogeras KI, Vrachatis DA, Moldovan C, Tousoulis D, Stefanadis C.

Curr Med Chem. 2012;19(16):2485-96. Review.

PMID:
22489719
[PubMed - indexed for MEDLINE]
5.

Candidate circulating biomarkers for the cardiovascular disease continuum.

Dotsenko O, Chackathayil J, Patel JV, Gill PS, Lip GY.

Curr Pharm Des. 2008;14(24):2445-61. Review.

PMID:
18781994
[PubMed - indexed for MEDLINE]
6.

Developing and assessing cardiovascular biomarkers.

Dadu RT, Nambi V, Ballantyne CM.

Transl Res. 2012 Apr;159(4):265-76. doi: 10.1016/j.trsl.2012.01.003. Epub 2012 Jan 27. Review.

PMID:
22424430
[PubMed - indexed for MEDLINE]
7.

Inflammatory biomarkers for predicting cardiovascular disease.

Stoner L, Lucero AA, Palmer BR, Jones LM, Young JM, Faulkner J.

Clin Biochem. 2013 Oct;46(15):1353-71. doi: 10.1016/j.clinbiochem.2013.05.070. Epub 2013 Jun 10. Review.

PMID:
23756129
[PubMed - indexed for MEDLINE]
8.

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events.

Torres JL, Ridker PM.

Curr Opin Cardiol. 2003 Nov;18(6):471-8. Review.

PMID:
14597888
[PubMed - indexed for MEDLINE]
9.

Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk.

Kajinami K, Kawai Y.

Atherosclerosis. 2011 Jan;214(1):39-40. doi: 10.1016/j.atherosclerosis.2010.09.028. Epub 2010 Oct 7. No abstract available.

PMID:
21036356
[PubMed - indexed for MEDLINE]
10.

Multiple biomarkers for predicting cardiovascular events: lessons learned.

Wang TJ.

J Am Coll Cardiol. 2010 May 11;55(19):2092-5. doi: 10.1016/j.jacc.2010.02.019. No abstract available.

PMID:
20447531
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction.

Schneider HJ, Wallaschofski H, Völzke H, Markus MR, Doerr M, Felix SB, Nauck M, Friedrich N.

PLoS One. 2012;7(3):e33084. doi: 10.1371/journal.pone.0033084. Epub 2012 Mar 16.

PMID:
22438892
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Circulating biomarkers.

Badimon L, Romero JC, Cubedo J, Borrell-Pagès M.

Thromb Res. 2012 Oct;130 Suppl 1:S12-5. doi: 10.1016/j.thromres.2012.08.262. Review.

PMID:
23026650
[PubMed - indexed for MEDLINE]
14.

Toward new biomarkers of cardiometabolic diseases.

Roberts LD, Gerszten RE.

Cell Metab. 2013 Jul 2;18(1):43-50. doi: 10.1016/j.cmet.2013.05.009. Epub 2013 Jun 13. Review.

PMID:
23770128
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.

Shlipak MG, Ix JH, Bibbins-Domingo K, Lin F, Whooley MA.

Am J Med. 2008 Jan;121(1):50-7. doi: 10.1016/j.amjmed.2007.06.030.

PMID:
18187073
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities.

Sattar N.

Diabet Med. 2012 Jan;29(1):5-13. doi: 10.1111/j.1464-5491.2011.03480.x. Review.

PMID:
21988593
[PubMed - indexed for MEDLINE]
17.

Urine albumin/creatinine ratio, high sensitivity C-reactive protein and N-terminal pro brain natriuretic peptide--three new cardiovascular risk markers--do they improve risk prediction and influence treatment?

Olsen MH, Sehestedt T, Lyngbaek S, Hansen TW, Rasmussen S, Wachtell K, Torp-Pedersen C, Hildebrandt PR, Ibsen H.

Curr Vasc Pharmacol. 2010 Jan;8(1):134-9.

PMID:
19485906
[PubMed - indexed for MEDLINE]
18.

Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events.

Huang PH, Chen JW, Lu TM, Yu-An Ding P, Lin SJ.

Clin Cardiol. 2007 Mar;30(3):135-40.

PMID:
17385705
[PubMed - indexed for MEDLINE]
19.

C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease.

Ridker PM.

Clin Chem. 2009 Feb;55(2):209-15. doi: 10.1373/clinchem.2008.119214. Epub 2008 Dec 18. No abstract available.

PMID:
19095723
[PubMed - indexed for MEDLINE]
Free Article
20.

Cardiac biomarkers: myths, facts and future horizons.

Dotsenko O, Chackathayil J, Lip GY.

Expert Rev Mol Diagn. 2007 Nov;7(6):693-7. Review. No abstract available.

PMID:
18020898
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk